05
Dec
2024
14:00
GMT
09:00
EST
Webinar
Cumulative Review of Hypertension in Patients with Chronic Lymphocytic Leukemia (CLL) and Other Hematologic Malignancies Treated with Acalabrutinib
00
Days
00
Hours
00
Mins
00
Secs
Faculty:
Anecita P. Fadol
Alessandra Ferrajoli
Dan Lenihan
Joe Carver
Overview
Join Dr Anecita Fadol (University of Texas MD Anderson Cancer Center, US), Dr Alessandra Ferrajoli (University of Texas, MD Anderson Cancer Center, US), Dr Dan Lenihan (Saint Francis Healthcare System, US) and Dr Joe Carver (University of Pennsylvania, US) as they provides an in-depth cumulative review of hypertension management in patients with Chronic Lymphocytic Leukemia (CLL) and other hematologic malignancies treated with Acalabrutinib.
This webinar will explore the mechanisms, incidence and clinical implications of treatment-related hypertension, offering cardiologists evidence-based strategies to optimise cardiovascular care for this patient population. Don’t miss this opportunity to deepen your understanding and connect with fellow professionals in the field.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This webinar is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Support Statement
This is an independent activity run by the International Cardio-oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. IC-OS has been provided support to deliver this webinar series by AstraZeneca, BeiGene, BMS/Pfizer Alliance, Eli Lilly and Sumitomo Pharma through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
This webinar is supported by
Faculty Biographies
Anecita P. Fadol
Dr Anecita Fadol, PhD, FNP-BC, FAANP, FAAN is an Associate Professor in the department of nursing with a joint appointment in the department of cardiology at The University of Texas MD Anderson Cancer Center. Dr Fadol is a nursing pioneer in the evolving field of cardio-oncology. Her extensive and unique expertise in cardio-oncology have been recognised nationally and internationally. She has written numerous book chapters, published in peer-reviewed journals, and is the editor of the “Cardiac
Complications of Cancer Therapy”.
Her programme of research included the validation of the MD Anderson Symptom Inventory-Heart Failure (MDASI-HF) instrument, which was subsequently translated to Chinese and Spanish. She was on the leadership council for the Cardio-Oncology section of the American College of Cardiology. Dr Fadol is a fellow of the American Academy of Nurse Practitioners, American Academy of Nursing, and was recently awarded as the 2021 Honorary Fellow in Cardiac Nursing by the Hong Kong Academy of Nursing.
Alessandra Ferrajoli
Dr Ferrajoli is an Academic Hematologist/Oncologist practicing in the Leukemia Department at the University of Texas, MD Anderson since 1998. Her main area of interest includes the treatment and Biology of Chronic Lymphocytic Leukemia and its variants, and treatment of elderly patients with Acute and Chronic Leukemia. In these fields Dr. Ferrajoli has authored and co- authored more than two hundred and fifty publications in peer reviewed journals.
Dr Ferrajoli serves on numerous journal editorial boards and grant proposal study sessions for several US and European Agencies. Dr Ferrajoli is a member of professional societies such the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), International Society of Geriatric Oncology (SIOG), the European Society for Medical Oncology (ESMO) and the European Hematology Association (EHA).
Dan Lenihan
Dr Dan Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Joe Carver
Dr Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.